Skip to main content

This translation is provided for general access and has no recorded medical-language review.

Editorial general information — not a clinical-review record

Published: Updated: Publisher: Dr. Murat Toktamışoğlu

How are eyelid and brow positions assessed before botulinum toxin?

Resting brow position, forehead compensation, eyelid droop and periocular conditions can change planning and risk communication. Botulinum toxin products, authorised uses and units are not equivalent; product, area, anatomy and dose require separate verification.

This translation has no recorded clinical or medical-language review.

Direct answer

  • Resting brow position, forehead compensation, eyelid droop and periocular conditions can change planning and risk communication.
  • Botulinum toxin products, authorised uses and units are not equivalent; product, area, anatomy and dose require separate verification.
  • Report visual-field symptoms, previous eye or lid surgery and dryness, and demonstrate opening the eyes without lifting the brows.

Assessment framework

Resting brow position, forehead compensation, eyelid droop and periocular conditions can change planning and risk communication. Botulinum toxin products, authorised uses and units are not equivalent; product, area, anatomy and dose require separate verification. This information is not a diagnosis, prescription, personal suitability decision or fixed procedure plan.

Questions for consultation

Report visual-field symptoms, previous eye or lid surgery and dryness, and demonstrate opening the eyes without lifting the brows. Alternatives, the option of no procedure, material risks, follow-up and urgent warning signs should also be discussed individually.

Scope of this article

This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.

Sources and evidence limits

These links are editorial starting points used to examine the article's boundaries.

  1. BOTOX Cosmetic (onabotulinumtoxinA) Prescribing Information

    U.S. Food and Drug Administration (FDA) · 2024

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  2. Cosmetic Botulinum Toxin A Injections to the Upper Face: A Systematic Review and Meta-Analysis of Clinical Studies

    Alaa Safia, Uday Abd Elhadi, Shlomo Merchavy, Ramzy Batheesh, Naji Bathish · 2026

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  3. Complications of Cosmetic Botulinum Toxin A Injections to the Upper Face: A Systematic Review and Meta-Analysis

    David Zargaran, Florence Zoller, Alexander Zargaran, Eqram Rahman, Alexander Woollard, Tim Weyrich, Afshin Mosahebi · 2022

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review